Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL152181 | 0.93 | RNASE1 (0.48) | RNASE1DUT | |
| SCHEMBL3923808 | 0.87 | DUT (0.59) | DUT | |
| SCHEMBL9341952 | 0.85 | RNASE1 (0.46) | RNASE1DUT | |
| SCHEMBL152180 | 0.83 | DUT (0.58) | DUT | |
| SCHEMBL9342953 | 0.83 | RNASE1 (0.44) | RNASE1DUT | |
| SCHEMBL6514624 | 0.81 | RNASE1 (0.47) | RNASE1DUT | |
| SCHEMBL9342955 | 0.80 | RNASE1 (0.42) | RNASE1DUT | |
| SCHEMBL6514654 | 0.80 | RNASE1 (0.48) | RNASE1 | |
| SCHEMBL6536529 | 0.80 | RNASE1 (0.48) | RNASE1 | |
| SCHEMBL22819137 | 0.80 | DUT (0.49) | RNASE1DUT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020068275-A1 | METHODS OF USING A CHIMERIC NUCLEIC ACID/NUCLEIC ACID ANALOGUE MOLECULE | AMERSHAM INTERNATIONAL PLC (GB) | 2002-06-06 | — | — | US | disclosed |
| EP-0720615-B1 | ELONGATION, AMPLIFICATION AND SEQUENCE DETERMINATION USING A CHIMERIC OLIGONUCLEOTIDE | AMERSHAM PHARM BIOTECH UK LTD (GB) | 2000-07-26 | — | — | EP | disclosed |
| EP-0720615-A1 | REAGENTS COMPRISING CHIMERIC MOLECULES OF NUCLEIC ACIDS AND NUCLEIC ACID ANALOGS | AMERSHAM INTERNATIONAL plc (GB) | 1996-07-10 | — | — | EP | disclosed |
| WO-1995008556-A1 | REAGENTS COMPRISING CHIMERIC MOLECULES OF NUCLEIC ACIDS AND NUCLEIC ACID ANALOGS | AMERSHAM INTERNATIONAL PLC (GB) | 1995-03-30 | — | — | WO | disclosed |